{"transactions":[{"id":4618346,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-09-15T20:59:35.000Z","date":"2026-09-14","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":7.8415,"value":15683.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.80 to $7.90. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 3,800 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":9383,"source":{"system":"sec-edgar","filing":"0001193125-26-392093","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000119312526392093/ownership.xml","form_type":"4"}},{"id":685142,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":22773,"kind":"person","name":"Nicacio Leonardo Viana","position":1,"cik":"0002064901","reported_name":"Nicacio Leonardo Viana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock options (right to buy)","published_at":"2026-08-17T20:30:04.000Z","date":"2026-08-16","kind":"grant","planned":false,"acquired":true,"shares":191676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option award was made in accordance with the terms of the issuer's 2026 Inducement Award Plan. 25% of the option vests on August 3, 2027, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on September 3, 2027."}],"balance_after":191676,"derivative":{"exercise_price":10.09,"expiration_date":"2036-08-16","underlying":"Common Stock","underlying_shares":191676},"source":{"system":"sec-edgar","filing":"0001193125-26-354145","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526354145/ownership.xml","form_type":"4"}},{"id":685141,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":22773,"kind":"person","name":"Nicacio Leonardo Viana","position":1,"cik":"0002064901","reported_name":"Nicacio Leonardo Viana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-08-17T20:30:04.000Z","date":"2026-08-16","kind":"grant","planned":false,"acquired":true,"shares":58333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 16, 2026, the Reporting Person was granted 58,333 restricted stock units (\"RSUs\"), which will be settled in shares of common stock, par value $0.0001. 25% of the RSUs shall vest on each of the first, second, third and fourth annual anniversary beginning on August 16, 2027. Notwithstanding the foregoing, upon termination of the Reporting Person's Service by the Company without cause, provided that such termination occurs after the first Vesting Date, then a prorata portion of the RSUs shall accelerate in an amount equal to the product of (x) the number of RSUs scheduled to vest on the next Vesting Date and (y) a fraction, the numerator of which is the number of completed months of service the Awardee worked since the most recent Vesting Date through the date of Awardee's termination of Service and the denominator of which is 12. The RSUs, to the extent not accelerated in accordance with this paragraph shall be forfeited upon such Reporting Person's termination of service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 58,333 unvested RSUs granted on August 16, 2026."}],"balance_after":58333,"source":{"system":"sec-edgar","filing":"0001193125-26-354145","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526354145/ownership.xml","form_type":"4"}},{"id":688924,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24022,"kind":"person","name":"Saxena Nishant C","position":1,"cik":"0002136365","reported_name":"Saxena Nishant C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-08-12T20:30:08.000Z","date":"2026-08-11","kind":"purchase","planned":false,"acquired":true,"shares":2600,"price":9.6294,"value":25036.44,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 58,300 unvested RSUs subject to the grant's vesting schedule as previously reported."}],"balance_after":77900,"source":{"system":"sec-edgar","filing":"0001193125-26-346966","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526346966/ownership.xml","form_type":"4"}},{"id":691671,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-08-10T20:30:09.000Z","date":"2026-08-07","kind":"sale","planned":true,"acquired":false,"shares":17000,"price":10.0821,"value":171395.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.18. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 138,049 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":157316,"source":{"system":"sec-edgar","filing":"0001193125-26-342485","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526342485/ownership.xml","form_type":"4"}},{"id":691814,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-08-10T20:30:03.000Z","date":"2026-08-07","kind":"sale","planned":true,"acquired":false,"shares":12000,"price":10.0809,"value":120970.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.25. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 68,795 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":84694,"source":{"system":"sec-edgar","filing":"0001193125-26-342479","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000119312526342479/ownership.xml","form_type":"4"}},{"id":741224,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-06-11T20:30:12.000Z","date":"2026-06-10","kind":"sale","planned":true,"acquired":false,"shares":2412,"price":7.9137,"value":19087.8444,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.71 to $7.97. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 3,800 unvested RSUs subject to the grant's vesting schedule as previously reported."}],"balance_after":7579,"source":{"system":"sec-edgar","filing":"0001193125-26-267655","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526267655/ownership.xml","form_type":"4"}},{"id":741741,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39288,"kind":"person","name":"Jenkins John Kenneth","position":1,"cik":"0001742557","reported_name":"Jenkins John Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-06-11T20:30:11.000Z","date":"2026-06-10","kind":"sale","planned":true,"acquired":false,"shares":4800,"price":7.9137,"value":37985.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.71 to $7.97. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 3,800 unvested RSUs subject to the grant's vesting schedule as previously reported."}],"balance_after":3833,"source":{"system":"sec-edgar","filing":"0001193125-26-267671","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742557/000119312526267671/ownership.xml","form_type":"4"}},{"id":741693,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-06-11T16:30:13.000Z","date":"2026-06-10","kind":"sale","planned":true,"acquired":false,"shares":2026,"price":7.9137,"value":16033.1562,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.71 to $7.97. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 3,800 unvested RSUs subject to the grant's vesting schedule as previously reported."}],"balance_after":12140,"source":{"system":"sec-edgar","filing":"0001193125-26-267672","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000119312526267672/ownership.xml","form_type":"4"}},{"id":750864,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24022,"kind":"person","name":"Saxena Nishant C","position":1,"cik":"0002136365","reported_name":"Saxena Nishant C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-06-03T21:36:50.000Z","date":"2026-06-03","kind":"purchase","planned":false,"acquired":true,"shares":9000,"price":7.58,"value":68220.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 58,300 unvested RSUs subject to the grant's vesting schedule as previously reported."}],"balance_after":75300,"source":{"system":"sec-edgar","filing":"0001193125-26-255834","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526255834/ownership.xml","form_type":"4"}},{"id":750863,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24022,"kind":"person","name":"Saxena Nishant C","position":1,"cik":"0002136365","reported_name":"Saxena Nishant C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-06-03T21:36:50.000Z","date":"2026-06-02","kind":"purchase","planned":false,"acquired":true,"shares":4500,"price":7.333,"value":32998.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.33 to $7.34. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 58,300 unvested RSUs subject to the grant's vesting schedule as previously reported."}],"balance_after":66300,"source":{"system":"sec-edgar","filing":"0001193125-26-255834","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526255834/ownership.xml","form_type":"4"}},{"id":765397,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24022,"kind":"person","name":"Saxena Nishant C","position":1,"cik":"0002136365","reported_name":"Saxena Nishant C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock options (right to buy)","published_at":"2026-05-22T20:51:32.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":192300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. 25% of the option vests on May 21, 2027, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on June 21, 2027."}],"balance_after":192300,"derivative":{"exercise_price":11.51,"expiration_date":"2036-05-21","underlying":"Common Stock","underlying_shares":192300},"source":{"system":"sec-edgar","filing":"0001193125-26-237103","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526237103/ownership.xml","form_type":"4"}},{"id":765396,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24022,"kind":"person","name":"Saxena Nishant C","position":1,"cik":"0002136365","reported_name":"Saxena Nishant C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-05-22T20:51:32.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":58300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 21, 2026, the Reporting Person was granted 58,300 restricted stock units (\"RSUs\"), which will be settled in shares of common stock, par value $0.0001. 25% of the RSUs shall vest on each of the first, second, third and fourth annual anniversary beginning on May 21, 2027. Notwithstanding the foregoing, upon termination of the Reporting Person's Service by the Company without cause, provided that such termination occurs after the first Vesting Date, then a prorata portion of the RSUs shall accelerate in an amount equal to the product of (x) the number of RSUs scheduled to vest on the next Vesting Date and (y) a fraction, the numerator of which is the number of completed months of service the Awardee worked since the most recent Vesting Date through the date of Awardees termination of Service and the denominator of which is 12. The RSUs, to the extent not accelerated in accordance with this paragraph shall be forfeited upon such Reporting Person's termination of service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 58,300 unvested RSUs granted on May 21, 2026."}],"balance_after":61800,"source":{"system":"sec-edgar","filing":"0001193125-26-237103","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526237103/ownership.xml","form_type":"4"}},{"id":767483,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2026-05-21T21:06:49.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":12300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":12300,"derivative":{"exercise_price":9.15,"expiration_date":"2026-05-19","underlying":"Common Stock","underlying_shares":12300},"source":{"system":"sec-edgar","filing":"0001193125-26-234857","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526234857/ownership.xml","form_type":"4"}},{"id":767482,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-05-21T21:06:49.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 19, 2026, 3,800 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 8,600 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":11383,"source":{"system":"sec-edgar","filing":"0001193125-26-234857","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526234857/ownership.xml","form_type":"4"}},{"id":768071,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39288,"kind":"person","name":"Jenkins John Kenneth","position":1,"cik":"0001742557","reported_name":"Jenkins John Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2026-05-21T21:06:21.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":12300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":12300,"derivative":{"exercise_price":9.15,"expiration_date":"2026-05-19","underlying":"Common Stock","underlying_shares":12300},"source":{"system":"sec-edgar","filing":"0001193125-26-234853","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1742557/000119312526234853/ownership.xml","form_type":"4"}},{"id":768070,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39288,"kind":"person","name":"Jenkins John Kenneth","position":1,"cik":"0001742557","reported_name":"Jenkins John Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-05-21T21:06:21.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 19, 2026, 3,800 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 8,600 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":8633,"source":{"system":"sec-edgar","filing":"0001193125-26-234853","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742557/000119312526234853/ownership.xml","form_type":"4"}},{"id":767481,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2026-05-21T21:05:51.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":12300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":12300,"derivative":{"exercise_price":9.15,"expiration_date":"2026-05-19","underlying":"Common Stock","underlying_shares":12300},"source":{"system":"sec-edgar","filing":"0001193125-26-234851","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526234851/ownership.xml","form_type":"4"}},{"id":767480,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-05-21T21:05:51.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 19, 2026, 3,800 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 8,600 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":9991,"source":{"system":"sec-edgar","filing":"0001193125-26-234851","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526234851/ownership.xml","form_type":"4"}},{"id":768203,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2026-05-21T21:05:25.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":12300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":12300,"derivative":{"exercise_price":9.15,"expiration_date":"2026-05-19","underlying":"Common Stock","underlying_shares":12300},"source":{"system":"sec-edgar","filing":"0001193125-26-234850","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000119312526234850/ownership.xml","form_type":"4"}},{"id":768202,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-05-21T21:05:25.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 19, 2026, 3,800 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 8,600 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":11383,"source":{"system":"sec-edgar","filing":"0001193125-26-234850","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000119312526234850/ownership.xml","form_type":"4"}},{"id":767479,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":22289,"kind":"person","name":"Pfeiffenberger Brent","position":1,"cik":"0002001162","reported_name":"Pfeiffenberger Brent","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2026-05-21T21:04:18.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":24700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to continued service to the Company through each applicable vesting date."}],"balance_after":24700,"derivative":{"exercise_price":9.15,"expiration_date":"2036-05-19","underlying":"Common Stock","underlying_shares":24700},"source":{"system":"sec-edgar","filing":"0001193125-26-234813","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526234813/ownership.xml","form_type":"4"}},{"id":767478,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":22289,"kind":"person","name":"Pfeiffenberger Brent","position":1,"cik":"0002001162","reported_name":"Pfeiffenberger Brent","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-05-21T21:04:18.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 19, 2026, 7,500 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to continued service to the Company through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 7,500 unvested RSUs that were granted on May 19, 2026 and will vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to continued service to the Company through each applicable vesting date."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001193125-26-234813","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526234813/ownership.xml","form_type":"4"}},{"id":767999,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2026-05-21T17:07:10.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":12300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":12300,"derivative":{"exercise_price":9.15,"expiration_date":"2026-05-19","underlying":"Common Stock","underlying_shares":12300},"source":{"system":"sec-edgar","filing":"0001193125-26-234860","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000119312526234860/ownership.xml","form_type":"4"}},{"id":767998,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-05-21T17:07:10.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 19, 2026, 3,800 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 8,600 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":14166,"source":{"system":"sec-edgar","filing":"0001193125-26-234860","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000119312526234860/ownership.xml","form_type":"4"}},{"id":860688,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":62756,"kind":"person","name":"Smethurst Dominic","position":1,"cik":"0001820549","reported_name":"Smethurst Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-03-04T21:30:18.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":6097,"price":8.2994,"value":50601.4418,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.20 to $8.35. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 73,765 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":89790,"source":{"system":"sec-edgar","filing":"0001193125-26-091647","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526091647/ownership.xml","form_type":"4"}},{"id":896617,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-02-18T21:31:03.000Z","date":"2026-02-13","kind":"sale","planned":true,"acquired":false,"shares":4701,"price":7.783,"value":36587.883,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025 and the sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.58 to $7.96. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 68,795 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":96694,"source":{"system":"sec-edgar","filing":"0001193125-26-057168","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000119312526057168/ownership.xml","form_type":"4"}},{"id":895817,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-02-18T21:30:13.000Z","date":"2026-02-13","kind":"sale","planned":true,"acquired":false,"shares":13871,"price":7.7826,"value":107952.4446,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025 and the sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.58 to $7.96. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 138,049 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":174316,"source":{"system":"sec-edgar","filing":"0001193125-26-057159","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526057159/ownership.xml","form_type":"4"}},{"id":897531,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":65949,"kind":"person","name":"Hodgson Ian","position":1,"cik":"0002057525","reported_name":"Hodgson Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-02-18T16:32:02.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":847,"price":7.383,"value":6253.401,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.37 to $7.42. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 46,362 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":51080,"source":{"system":"sec-edgar","filing":"0001193125-26-057174","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2057525/000119312526057174/ownership.xml","form_type":"4"}},{"id":919036,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":62756,"kind":"person","name":"Smethurst Dominic","position":1,"cik":"0001820549","reported_name":"Smethurst Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-02-04T21:25:42.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":3285,"price":8.0898,"value":26574.993,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $8.15. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 86,265 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":95887,"source":{"system":"sec-edgar","filing":"0001193125-26-037647","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526037647/ownership.xml","form_type":"4"}},{"id":919755,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":65949,"kind":"person","name":"Hodgson Ian","position":1,"cik":"0002057525","reported_name":"Hodgson Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-02-04T16:24:39.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":2415,"price":8.0899,"value":19537.1085,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $8.15. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 48,108 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":51927,"source":{"system":"sec-edgar","filing":"0001193125-26-037643","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2057525/000119312526037643/ownership.xml","form_type":"4"}},{"id":936744,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":62756,"kind":"person","name":"Smethurst Dominic","position":1,"cik":"0001820549","reported_name":"Smethurst Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock options (right to buy)","published_at":"2026-01-16T21:30:10.000Z","date":"2026-01-14","kind":"grant","planned":false,"acquired":true,"shares":85095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. 25% of the option vests on January 14, 2027, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 14, 2027."}],"balance_after":85095,"derivative":{"exercise_price":8.26,"expiration_date":"2036-01-14","underlying":"Common Stock","underlying_shares":85095},"source":{"system":"sec-edgar","filing":"0001193125-26-015429","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526015429/ownership.xml","form_type":"4"}},{"id":936743,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":62756,"kind":"person","name":"Smethurst Dominic","position":1,"cik":"0001820549","reported_name":"Smethurst Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-01-16T21:30:10.000Z","date":"2026-01-14","kind":"grant","planned":false,"acquired":true,"shares":28365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 14, 2026, the Reporting Person was granted 28,365 restricted stock units (\"RSUs\"), which will be settled in shares of common stock, par value $0.0001. 25% of the RSUs shall vest on each of the first, second, third and fourth anniversary beginning on January 14, 2027. Notwithstanding the foregoing, upon termination of the Reporting Person's Service by the Company without cause, provided that such termination occurs after the first Vesting Date, then a pro rata portion of the RSUs shall accelerate in an amount equal to the product of (x) the number of RSUs scheduled to vest on the next Vesting Date and (y) a fraction, the numerator of which is the number of completed months of service the Awardee worked since the most recent Vesting Date through the date of Awardees termination of Service and the denominator of which is 12. The RSUs, to the extent not accelerated in accordance with this paragraph shall be forfeited upon such Reporting Person's termination of service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 93,065 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":99172,"source":{"system":"sec-edgar","filing":"0001193125-26-015429","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526015429/ownership.xml","form_type":"4"}},{"id":937132,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock options (right to buy)","published_at":"2026-01-16T21:30:06.000Z","date":"2026-01-14","kind":"grant","planned":false,"acquired":true,"shares":84247,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. 25% of the option vests on January 14, 2027, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 14, 2027."}],"balance_after":84247,"derivative":{"exercise_price":8.26,"expiration_date":"2036-01-14","underlying":"Common Stock","underlying_shares":84247},"source":{"system":"sec-edgar","filing":"0001193125-26-015427","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000119312526015427/ownership.xml","form_type":"4"}},{"id":937131,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-01-16T21:30:06.000Z","date":"2026-01-14","kind":"grant","planned":false,"acquired":true,"shares":28082,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 14, 2026, the Reporting Person was granted 28,082 restricted stock units (\"RSUs\"), which will be settled in shares of common stock, par value $0.0001. 25% of the RSUs shall vest on each of the first, second, third and fourth anniversary beginning on January 14, 2027. Notwithstanding the foregoing, upon termination of the Reporting Person's Service by the Company without cause, provided that such termination occurs after the first Vesting Date, then a pro rata portion of the RSUs shall accelerate in an amount equal to the product of (x) the number of RSUs scheduled to vest on the next Vesting Date and (y) a fraction, the numerator of which is the number of completed months of service the Awardee worked since the most recent Vesting Date through the date of Awardees termination of Service and the denominator of which is 12. The RSUs, to the extent not accelerated in accordance with this paragraph shall be forfeited upon such Reporting Person's termination of service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 85,714 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":101395,"source":{"system":"sec-edgar","filing":"0001193125-26-015427","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000119312526015427/ownership.xml","form_type":"4"}},{"id":936746,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock options (right to buy)","published_at":"2026-01-16T21:30:05.000Z","date":"2026-01-14","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. 25% of the option vests on January 14, 2027, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 14, 2027."}],"balance_after":150000,"derivative":{"exercise_price":8.26,"expiration_date":"2036-01-14","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001193125-26-015426","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526015426/ownership.xml","form_type":"4"}},{"id":936745,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-01-16T21:30:05.000Z","date":"2026-01-14","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 14, 2026, the Reporting Person was granted 50,000 restricted stock units (\"RSUs\"), which will be settled in shares of common stock, par value $0.0001. 25% of the RSUs shall vest on each of the first, second, third and fourth anniversary beginning on January 14, 2027. Notwithstanding the foregoing, upon termination of the Reporting Person's Service by the Company without cause, provided that such termination occurs after the first Vesting Date, then a prorata portion of the RSUs shall accelerate in an amount equal to the product of (x) the number of RSUs scheduled to vest on the next Vesting Date and (y) a fraction, the numerator of which is the number of completed months of service the Awardee worked since the most recent Vesting Date through the date of Awardees termination of Service and the denominator of which is 12. The RSUs, to the extent not accelerated in accordance with this paragraph shall be forfeited upon such Reporting Person's termination of service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 173,561 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":188187,"source":{"system":"sec-edgar","filing":"0001193125-26-015426","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526015426/ownership.xml","form_type":"4"}},{"id":937487,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":65949,"kind":"person","name":"Hodgson Ian","position":1,"cik":"0002057525","reported_name":"Hodgson Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock options (right to buy)","published_at":"2026-01-16T16:30:03.000Z","date":"2026-01-14","kind":"grant","planned":false,"acquired":true,"shares":85095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. 25% of the option vests on January 14, 2027, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 14, 2027."}],"balance_after":85095,"derivative":{"exercise_price":8.26,"expiration_date":"2036-01-14","underlying":"Common Stock","underlying_shares":85095},"source":{"system":"sec-edgar","filing":"0001193125-26-015430","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2057525/000119312526015430/ownership.xml","form_type":"4"}},{"id":937486,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":65949,"kind":"person","name":"Hodgson Ian","position":1,"cik":"0002057525","reported_name":"Hodgson Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-01-16T16:30:03.000Z","date":"2026-01-14","kind":"grant","planned":false,"acquired":true,"shares":28365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 14, 2026, the Reporting Person was granted 28,365 restricted stock units (\"RSUs\"), which will be settled in shares of common stock, par value $0.0001. 25% of the RSUs shall vest on each of the first, second, third and fourth anniversary beginning on January 14, 2027. Notwithstanding the foregoing, upon termination of the Reporting Person's Service by the Company without cause, provided that such termination occurs after the first Vesting Date, then a pro rata portion of the RSUs shall accelerate in an amount equal to the product of (x) the number of RSUs scheduled to vest on the next Vesting Date and (y) a fraction, the numerator of which is the number of completed months of service the Awardee worked since the most recent Vesting Date through the date of Awardees termination of Service and the denominator of which is 12. The RSUs, to the extent not accelerated in accordance with this paragraph shall be forfeited upon such Reporting Person's termination of service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 53,108 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":54342,"source":{"system":"sec-edgar","filing":"0001193125-26-015430","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2057525/000119312526015430/ownership.xml","form_type":"4"}},{"id":968846,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-12-15T21:18:06.000Z","date":"2025-12-11","kind":"sale","planned":false,"acquired":false,"shares":30029,"price":11.456,"value":344012.224,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price represents the weighted average sale price of Common Stock (the \"shares\") sold in a series of open market transactions on the transaction date at prices ranging from $11.20 to $12.15 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were sold by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as the general partner of the Master Fund. Bihua Chen serves as the managing member of Cormorant, GP LLC and the Master Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":2344971,"source":{"system":"sec-edgar","filing":"0000929638-25-004597","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963825004597/form4.xml","form_type":"4"}},{"id":1013099,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock options (right to buy)","published_at":"2025-10-27T20:23:19.000Z","date":"2025-10-27","kind":"exercise","planned":true,"acquired":false,"shares":8973,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vested on February 13, 2024, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 13, 2024."}],"balance_after":22106,"derivative":{"exercise_price":4.26,"exercise_date":"2024-02-13","expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":8973},"source":{"system":"sec-edgar","filing":"0001193125-25-251639","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525251639/ownership.xml","form_type":"4"}},{"id":1013098,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock options (right to buy)","published_at":"2025-10-27T20:23:19.000Z","date":"2025-10-24","kind":"exercise","planned":true,"acquired":false,"shares":18660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vested on February 13, 2024, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 13, 2024."}],"balance_after":31079,"derivative":{"exercise_price":4.26,"exercise_date":"2024-02-13","expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":18660},"source":{"system":"sec-edgar","filing":"0001193125-25-251639","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525251639/ownership.xml","form_type":"4"}},{"id":1013097,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-10-27T20:23:19.000Z","date":"2025-10-27","kind":"sale","planned":true,"acquired":false,"shares":8973,"price":17.14,"value":153797.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.31. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 123,561 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":138187,"source":{"system":"sec-edgar","filing":"0001193125-25-251639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525251639/ownership.xml","form_type":"4"}},{"id":1013096,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-10-27T20:23:19.000Z","date":"2025-10-27","kind":"exercise","planned":true,"acquired":true,"shares":8973,"price":4.26,"value":38224.98,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 123,561 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":147160,"source":{"system":"sec-edgar","filing":"0001193125-25-251639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525251639/ownership.xml","form_type":"4"}},{"id":1013095,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-10-27T20:23:19.000Z","date":"2025-10-24","kind":"sale","planned":true,"acquired":false,"shares":18660,"price":17.01,"value":317406.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.79 to $17.38. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 123,561 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":138187,"source":{"system":"sec-edgar","filing":"0001193125-25-251639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525251639/ownership.xml","form_type":"4"}},{"id":1013094,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-10-27T20:23:19.000Z","date":"2025-10-24","kind":"exercise","planned":true,"acquired":true,"shares":18660,"price":4.26,"value":79491.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 123,561 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":156847,"source":{"system":"sec-edgar","filing":"0001193125-25-251639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525251639/ownership.xml","form_type":"4"}},{"id":1013216,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock options (right to buy)","published_at":"2025-10-27T20:22:21.000Z","date":"2025-10-24","kind":"exercise","planned":true,"acquired":false,"shares":12981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vested on February 13, 2024, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 13, 2024."}],"balance_after":10386,"derivative":{"exercise_price":4.26,"exercise_date":"2024-02-13","expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":12981},"source":{"system":"sec-edgar","filing":"0001193125-25-251635","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000119312525251635/ownership.xml","form_type":"4"}},{"id":1013215,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-10-27T20:22:21.000Z","date":"2025-10-24","kind":"sale","planned":true,"acquired":false,"shares":12981,"price":17.02,"value":220936.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.79 to $17.38. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 57,632 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":73313,"source":{"system":"sec-edgar","filing":"0001193125-25-251635","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000119312525251635/ownership.xml","form_type":"4"}},{"id":1013214,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-10-27T20:22:21.000Z","date":"2025-10-24","kind":"exercise","planned":true,"acquired":true,"shares":12981,"price":4.26,"value":55299.06,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 57,632 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":86294,"source":{"system":"sec-edgar","filing":"0001193125-25-251635","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000119312525251635/ownership.xml","form_type":"4"}},{"id":1015153,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2025-10-21T20:54:53.000Z","date":"2025-10-20","kind":"exercise","planned":true,"acquired":false,"shares":1060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested."}],"balance_after":4247,"derivative":{"exercise_price":4.8,"expiration_date":"2032-09-26","underlying":"Common Stock","underlying_shares":1060},"source":{"system":"sec-edgar","filing":"0001193125-25-245262","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525245262/ownership.xml","form_type":"4"}},{"id":1015152,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-10-21T20:54:53.000Z","date":"2025-10-20","kind":"sale","planned":true,"acquired":false,"shares":1060,"price":20.5,"value":21730.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 4,800 unvested RSUs that were granted on May 30, 2025 and vest 100% on the one-year anniversary of the date of grant."}],"balance_after":6191,"source":{"system":"sec-edgar","filing":"0001193125-25-245262","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525245262/ownership.xml","form_type":"4"}},{"id":1015151,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-10-21T20:54:53.000Z","date":"2025-10-20","kind":"exercise","planned":true,"acquired":true,"shares":1060,"price":4.8,"value":5088.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 4,800 unvested RSUs that were granted on May 30, 2025 and vest 100% on the one-year anniversary of the date of grant."}],"balance_after":7251,"source":{"system":"sec-edgar","filing":"0001193125-25-245262","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525245262/ownership.xml","form_type":"4"}},{"id":1127725,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39288,"kind":"person","name":"Jenkins John Kenneth","position":1,"cik":"0001742557","reported_name":"Jenkins John Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2025-06-02T20:30:16.000Z","date":"2025-05-30","kind":"grant","planned":true,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":16000,"derivative":{"exercise_price":7.42,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000950170-25-080311","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1742557/000095017025080311/ownership.xml","form_type":"4"}},{"id":1127724,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39288,"kind":"person","name":"Jenkins John Kenneth","position":1,"cik":"0001742557","reported_name":"Jenkins John Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-06-02T20:30:16.000Z","date":"2025-05-30","kind":"grant","planned":true,"acquired":true,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On May 30, 2025, 4,800 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This amount includes 4,800 unvested RSUs that were granted on May 30, 2025."}],"balance_after":4833,"source":{"system":"sec-edgar","filing":"0000950170-25-080311","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1742557/000095017025080311/ownership.xml","form_type":"4"}},{"id":1127723,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39288,"kind":"person","name":"Jenkins John Kenneth","position":1,"cik":"0001742557","reported_name":"Jenkins John Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-06-02T20:30:16.000Z","date":"2025-05-30","kind":"sale","planned":true,"acquired":false,"shares":2783,"price":7.3537,"value":20465.3471,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 29, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.21 to $7.53. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":33,"source":{"system":"sec-edgar","filing":"0000950170-25-080311","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742557/000095017025080311/ownership.xml","form_type":"4"}},{"id":1127886,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2025-06-02T20:30:15.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":16000,"derivative":{"exercise_price":7.42,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000950170-25-080312","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000095017025080312/ownership.xml","form_type":"4"}},{"id":1127885,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-06-02T20:30:15.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 30, 2025, 4,800 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 4,800 unvested RSUs that were granted on May 30, 2025."}],"balance_after":7583,"source":{"system":"sec-edgar","filing":"0000950170-25-080312","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000095017025080312/ownership.xml","form_type":"4"}},{"id":1127195,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2025-06-02T20:30:13.000Z","date":"2025-05-30","kind":"grant","planned":true,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":16000,"derivative":{"exercise_price":7.42,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000950170-25-080310","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025080310/ownership.xml","form_type":"4"}},{"id":1127194,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-06-02T20:30:13.000Z","date":"2025-05-30","kind":"grant","planned":true,"acquired":true,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On May 30, 2025, 4,800 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This amount includes 4,800 unvested RSUs that were granted on May 30, 2025."}],"balance_after":6191,"source":{"system":"sec-edgar","filing":"0000950170-25-080310","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025080310/ownership.xml","form_type":"4"}},{"id":1127193,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":39165,"kind":"person","name":"Altmeyer Anne","position":1,"cik":"0001947086","reported_name":"Altmeyer Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-06-02T20:30:13.000Z","date":"2025-05-30","kind":"sale","planned":true,"acquired":false,"shares":1392,"price":7.2526,"value":10095.6192,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.16 to $7.50. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1391,"source":{"system":"sec-edgar","filing":"0000950170-25-080310","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025080310/ownership.xml","form_type":"4"}},{"id":1127192,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2025-06-02T20:30:09.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":16000,"derivative":{"exercise_price":7.42,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000950170-25-080308","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025080308/ownership.xml","form_type":"4"}},{"id":1127191,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38561,"kind":"person","name":"Jacques Rachelle Suzanne","position":1,"cik":"0001772610","reported_name":"Jacques Rachelle Suzanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-06-02T20:30:09.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 30, 2025, 4,800 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 4,800 unvested RSUs that were granted on May 30, 2025."}],"balance_after":7583,"source":{"system":"sec-edgar","filing":"0000950170-25-080308","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025080308/ownership.xml","form_type":"4"}},{"id":1127656,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2025-06-02T16:30:18.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":16000,"derivative":{"exercise_price":7.42,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000950170-25-080313","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000095017025080313/ownership.xml","form_type":"4"}},{"id":1127655,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-06-02T16:30:18.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 30, 2025, 4,800 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 10,366 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":10366,"source":{"system":"sec-edgar","filing":"0000950170-25-080313","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000095017025080313/ownership.xml","form_type":"4"}},{"id":1127348,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":78996,"kind":"person","name":"HOLMER ALAN F","position":1,"cik":"0001329585","reported_name":"HOLMER ALAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2025-06-02T16:30:11.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":16000,"derivative":{"exercise_price":7.42,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000950170-25-080309","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1329585/000095017025080309/ownership.xml","form_type":"4"}},{"id":1127347,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":78996,"kind":"person","name":"HOLMER ALAN F","position":1,"cik":"0001329585","reported_name":"HOLMER ALAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-06-02T16:30:11.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 30, 2025, 4,800 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 4,800 unvested RSUs that were granted on May 30, 2025."}],"balance_after":10629,"source":{"system":"sec-edgar","filing":"0000950170-25-080309","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329585/000095017025080309/ownership.xml","form_type":"4"}},{"id":1216859,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":62756,"kind":"person","name":"Smethurst Dominic","position":1,"cik":"0001820549","reported_name":"Smethurst Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-03-07T21:30:08.000Z","date":"2025-03-06","kind":"sale","planned":false,"acquired":false,"shares":6393,"price":6.7777,"value":43329.8361,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.60 to $6.90. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 64,700 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":70807,"source":{"system":"sec-edgar","filing":"0000950170-25-035547","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025035547/ownership.xml","form_type":"4"}},{"id":1263638,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-02-18T22:40:54.000Z","date":"2025-02-14","kind":"sale","planned":true,"acquired":false,"shares":2792,"price":8.7559,"value":24446.4728,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024 and the sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.30 to $9.14. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 57,632 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":73313,"source":{"system":"sec-edgar","filing":"0000950170-25-022514","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000095017025022514/ownership.xml","form_type":"4"}},{"id":1263272,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-02-18T22:40:26.000Z","date":"2025-02-14","kind":"sale","planned":true,"acquired":false,"shares":7134,"price":8.7559,"value":62464.5906,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024 and the sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.30 to $9.14. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 123,561 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":138187,"source":{"system":"sec-edgar","filing":"0000950170-25-022512","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025022512/ownership.xml","form_type":"4"}},{"id":1283724,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":62756,"kind":"person","name":"Smethurst Dominic","position":1,"cik":"0001820549","reported_name":"Smethurst Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock options (right to buy)","published_at":"2025-02-04T22:14:53.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":91200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. 25% of the option vests on January 31, 2026, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 28, 2026."}],"balance_after":91200,"derivative":{"exercise_price":9.79,"expiration_date":"2035-01-31","underlying":"Common Stock","underlying_shares":91200},"source":{"system":"sec-edgar","filing":"0000950170-25-013704","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025013704/ownership.xml","form_type":"4"}},{"id":1283723,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":62756,"kind":"person","name":"Smethurst Dominic","position":1,"cik":"0001820549","reported_name":"Smethurst Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-02-04T22:14:53.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":27200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 31, 2025, the Reporting Person was granted 27,200 restricted stock units (\"RSUs\"), which will be settled in shares of common stock, par value $0.0001. 25% of the RSUs shall vest on each of the first, second, third and fourth anniversary beginning on January 31, 2026. Notwithstanding the foregoing, upon termination of the Reporting Person's Service by the Company without cause, provided that such termination occurs after the first Vesting Date, then a pro rata portion of the RSUs shall accelerate in an amount equal to the product of (x) the number of RSUs scheduled to vest on the next Vesting Date and (y) a fraction, the numerator of which is the number of completed months of service the Awardee worked since the most recent Vesting Date through the date of Awardees termination of Service and the denominator of which is 12. The RSUs, to the extent not accelerated in accordance with this paragraph shall be forfeited upon such Reporting Person's termination of service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 77,200 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":77200,"source":{"system":"sec-edgar","filing":"0000950170-25-013704","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025013704/ownership.xml","form_type":"4"}},{"id":1284599,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock options (right to buy)","published_at":"2025-02-04T22:13:17.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":92500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. 25% of the option vests on January 31, 2026, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 28, 2026."}],"balance_after":92500,"derivative":{"exercise_price":9.79,"expiration_date":"2035-01-31","underlying":"Common Stock","underlying_shares":92500},"source":{"system":"sec-edgar","filing":"0000950170-25-013702","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000095017025013702/ownership.xml","form_type":"4"}},{"id":1284598,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-02-04T22:13:17.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 31, 2025, the Reporting Person was granted 27,500 restricted stock units (\"RSUs\"), which will be settled in shares of common stock, par value $0.0001. 25% of the RSUs shall vest on each of the first, second, third and fourth anniversary beginning on January 31, 2026. Notwithstanding the foregoing, upon termination of the Reporting Person's Service by the Company without cause, provided that such termination occurs after the first Vesting Date, then a pro rata portion of the RSUs shall accelerate in an amount equal to the product of (x) the number of RSUs scheduled to vest on the next Vesting Date and (y) a fraction, the numerator of which is the number of completed months of service the Awardee worked since the most recent Vesting Date through the date of Awardees termination of Service and the denominator of which is 12. The RSUs, to the extent not accelerated in accordance with this paragraph shall be forfeited upon such Reporting Person's termination of service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 67,676 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":76105,"source":{"system":"sec-edgar","filing":"0000950170-25-013702","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000095017025013702/ownership.xml","form_type":"4"}},{"id":1283719,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock options (right to buy)","published_at":"2025-02-04T22:11:39.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":228800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. 25% of the option vests on January 31, 2026, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 28, 2026."}],"balance_after":228800,"derivative":{"exercise_price":9.79,"expiration_date":"2035-01-31","underlying":"Common Stock","underlying_shares":228800},"source":{"system":"sec-edgar","filing":"0000950170-25-013697","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025013697/ownership.xml","form_type":"4"}},{"id":1283718,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-02-04T22:11:39.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":68100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 31, 2025, the Reporting Person was granted 68,100 restricted stock units (\"RSUs\"), which will be settled in shares of common stock, par value $0.0001. 25% of the RSUs shall vest on each of the first, second, third and fourth anniversary beginning on January 31, 2026. Notwithstanding the foregoing, upon termination of the Reporting Person's Service by the Company without cause, provided that such termination occurs after the first Vesting Date, then a pro rata portion of the RSUs shall accelerate in an amount equal to the product of (x) the number of RSUs scheduled to vest on the next Vesting Date and (y) a fraction, the numerator of which is the number of completed months of service the Awardee worked since the most recent Vesting Date through the date of Awardees termination of Service and the denominator of which is 12. The RSUs, to the extent not accelerated in accordance with this paragraph shall be forfeited upon such Reporting Person's termination of service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 142,047 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":145321,"source":{"system":"sec-edgar","filing":"0000950170-25-013697","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025013697/ownership.xml","form_type":"4"}},{"id":1399919,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-09-24T20:04:18.000Z","date":"2024-09-20","kind":"purchase","planned":false,"acquired":true,"shares":25769,"price":22.228,"value":572793.332,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $22.00 to $22.50 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":2375000,"source":{"system":"sec-edgar","filing":"0000929638-24-003217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824003217/form4.xml","form_type":"4"}},{"id":1399918,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-09-24T20:04:18.000Z","date":"2024-09-20","kind":"purchase","planned":false,"acquired":true,"shares":47564,"price":21.474,"value":1021389.336,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $21.00 to $21.99 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":2349231,"source":{"system":"sec-edgar","filing":"0000929638-24-003217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824003217/form4.xml","form_type":"4"}},{"id":1399917,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-09-24T20:04:18.000Z","date":"2024-09-20","kind":"purchase","planned":false,"acquired":true,"shares":139551,"price":20.418,"value":2849352.318,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $20.00 to $20.995 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":2301667,"source":{"system":"sec-edgar","filing":"0000929638-24-003217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824003217/form4.xml","form_type":"4"}},{"id":1399916,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-09-24T20:04:18.000Z","date":"2024-09-20","kind":"purchase","planned":false,"acquired":true,"shares":66088,"price":19.611,"value":1296051.768,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $19.00 to $19.998 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":2162116,"source":{"system":"sec-edgar","filing":"0000929638-24-003217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824003217/form4.xml","form_type":"4"}},{"id":1399915,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-09-24T20:04:18.000Z","date":"2024-09-20","kind":"purchase","planned":false,"acquired":true,"shares":25943,"price":18.36,"value":476313.48,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $18.03 to $18.999 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":2096028,"source":{"system":"sec-edgar","filing":"0000929638-24-003217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824003217/form4.xml","form_type":"4"}},{"id":1399914,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-09-24T20:04:18.000Z","date":"2024-09-20","kind":"purchase","planned":false,"acquired":true,"shares":45085,"price":17.475,"value":787860.375,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $17.00 to $17.95 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission (the \"SEC\"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund (as defined below)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":2070085,"source":{"system":"sec-edgar","filing":"0000929638-24-003217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824003217/form4.xml","form_type":"4"}},{"id":1427651,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2024-08-20T16:48:47.000Z","date":"2024-08-16","kind":"grant","planned":false,"acquired":true,"shares":5566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":5566,"derivative":{"exercise_price":53.52,"expiration_date":"2034-08-16","underlying":"Common Stock","underlying_shares":5566},"source":{"system":"sec-edgar","filing":"0000950170-24-099175","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000095017024099175/ownership.xml","form_type":"4"}},{"id":1427650,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-08-20T16:48:47.000Z","date":"2024-08-16","kind":"grant","planned":false,"acquired":true,"shares":5566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 16, 2024, 5,566 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 5,566 unvested RSUs that were granted on August 16, 2024 and will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":5566,"source":{"system":"sec-edgar","filing":"0000950170-24-099175","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000095017024099175/ownership.xml","form_type":"4"}},{"id":1475119,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to purchase common stock","published_at":"2024-06-18T21:59:42.000Z","date":"2024-06-18","kind":"exercise","planned":true,"acquired":false,"shares":1958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":30,"expiration_date":"2024-10-22","underlying":"Common Stock","underlying_shares":1958},"source":{"system":"sec-edgar","filing":"0000950170-24-075075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000095017024075075/ownership.xml","form_type":"4"}},{"id":1475118,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to purchase common stock","published_at":"2024-06-18T21:59:42.000Z","date":"2024-06-17","kind":"exercise","planned":true,"acquired":false,"shares":6730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vested on February 1, 2023, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 2, 2023."}],"balance_after":11217,"derivative":{"exercise_price":14.1,"exercise_date":"2023-02-01","expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":6730},"source":{"system":"sec-edgar","filing":"0000950170-24-075075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000095017024075075/ownership.xml","form_type":"4"}},{"id":1475117,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to purchase common stock","published_at":"2024-06-18T21:59:42.000Z","date":"2024-06-14","kind":"exercise","planned":true,"acquired":false,"shares":7788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vested on February 13, 2024, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 13, 2024."}],"balance_after":23367,"derivative":{"exercise_price":4.26,"exercise_date":"2024-02-13","expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":7788},"source":{"system":"sec-edgar","filing":"0000950170-24-075075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000095017024075075/ownership.xml","form_type":"4"}},{"id":1475116,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to purchase common stock","published_at":"2024-06-18T21:59:42.000Z","date":"2024-06-14","kind":"exercise","planned":true,"acquired":false,"shares":1567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested."}],"balance_after":1958,"derivative":{"exercise_price":30,"expiration_date":"2024-10-22","underlying":"Common Stock","underlying_shares":1567},"source":{"system":"sec-edgar","filing":"0000950170-24-075075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000095017024075075/ownership.xml","form_type":"4"}},{"id":1475115,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:59:42.000Z","date":"2024-06-18","kind":"sale","planned":true,"acquired":false,"shares":1958,"price":42.1242,"value":82479.1836,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.10 to $43.59 per share, inclusive. The reporting person undertakes to provide to Corbus Pharmaceuticals Holdings, Inc., any security holder of Corbus Pharmaceuticals Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 40,176 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":48605,"source":{"system":"sec-edgar","filing":"0000950170-24-075075","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000095017024075075/ownership.xml","form_type":"4"}},{"id":1475114,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:59:42.000Z","date":"2024-06-18","kind":"exercise","planned":true,"acquired":true,"shares":1958,"price":30,"value":58740.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 40,176 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":50563,"source":{"system":"sec-edgar","filing":"0000950170-24-075075","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000095017024075075/ownership.xml","form_type":"4"}},{"id":1475113,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:59:42.000Z","date":"2024-06-17","kind":"sale","planned":true,"acquired":false,"shares":6730,"price":46.774,"value":314789.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.88 to $49.47 per share, inclusive. The reporting person undertakes to provide to Corbus Pharmaceuticals Holdings, Inc., any security holder of Corbus Pharmaceuticals Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 40,176 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":48605,"source":{"system":"sec-edgar","filing":"0000950170-24-075075","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000095017024075075/ownership.xml","form_type":"4"}},{"id":1475112,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:59:42.000Z","date":"2024-06-17","kind":"exercise","planned":true,"acquired":true,"shares":6730,"price":14.1,"value":94893.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 40,176 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":55335,"source":{"system":"sec-edgar","filing":"0000950170-24-075075","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000095017024075075/ownership.xml","form_type":"4"}},{"id":1475111,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:59:42.000Z","date":"2024-06-14","kind":"sale","planned":true,"acquired":false,"shares":7788,"price":49.8738,"value":388417.1544,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.26 to $52.525 per share, inclusive. The reporting person undertakes to provide to Corbus Pharmaceuticals Holdings, Inc., any security holder of Corbus Pharmaceuticals Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 40,176 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":48605,"source":{"system":"sec-edgar","filing":"0000950170-24-075075","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000095017024075075/ownership.xml","form_type":"4"}},{"id":1475110,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:59:42.000Z","date":"2024-06-14","kind":"exercise","planned":true,"acquired":true,"shares":7788,"price":4.26,"value":33176.88,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 40,176 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":56393,"source":{"system":"sec-edgar","filing":"0000950170-24-075075","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000095017024075075/ownership.xml","form_type":"4"}},{"id":1475109,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:59:42.000Z","date":"2024-06-14","kind":"sale","planned":true,"acquired":false,"shares":1567,"price":49.8738,"value":78152.2446,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.26 to $52.525 per share, inclusive. The reporting person undertakes to provide to Corbus Pharmaceuticals Holdings, Inc., any security holder of Corbus Pharmaceuticals Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 40,176 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":48605,"source":{"system":"sec-edgar","filing":"0000950170-24-075075","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000095017024075075/ownership.xml","form_type":"4"}},{"id":1475108,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24989,"kind":"person","name":"Moran Sean F.","position":1,"cik":"0001451495","reported_name":"Moran Sean F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:59:42.000Z","date":"2024-06-14","kind":"exercise","planned":true,"acquired":true,"shares":1567,"price":30,"value":47010.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 40,176 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":50172,"source":{"system":"sec-edgar","filing":"0000950170-24-075075","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451495/000095017024075075/ownership.xml","form_type":"4"}},{"id":1474671,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options to purchase common stock","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-18","kind":"exercise","planned":true,"acquired":false,"shares":2322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vested on February 13, 2024, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 13, 2024."}],"balance_after":49739,"derivative":{"exercise_price":4.26,"exercise_date":"2024-02-13","expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":2322},"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474670,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options to purchase common stock","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-18","kind":"exercise","planned":true,"acquired":false,"shares":1770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vested on February 1, 2023, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 2, 2023."}],"balance_after":31057,"derivative":{"exercise_price":14.1,"exercise_date":"2023-02-01","expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":1770},"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474669,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options to purchase common stock","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-18","kind":"exercise","planned":true,"acquired":false,"shares":11667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":30,"expiration_date":"2024-10-22","underlying":"Common Stock","underlying_shares":11667},"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474668,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options to purchase common stock","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-17","kind":"exercise","planned":true,"acquired":false,"shares":1770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vested on February 13, 2024, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 13, 2024."}],"balance_after":52061,"derivative":{"exercise_price":4.26,"exercise_date":"2024-02-13","expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":1770},"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474667,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options to purchase common stock","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-17","kind":"exercise","planned":true,"acquired":false,"shares":9333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested."}],"balance_after":11667,"derivative":{"exercise_price":30,"expiration_date":"2024-10-22","underlying":"Common Stock","underlying_shares":9333},"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}}],"next_cursor":"2024-06-18T21:58:48.000000Z,1474667"}